Loading the knowledge graph…

Knowledge graph · Cancer

Nasal Cavity Carcinoma

subtype

Identifier: CI-CAN-00006100
Entity page: /cancer/nasal-cavity-carcinoma ↗
Edges: 17

Neighbours: 10 drugs7 trials
Drawn: 17 of 17 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Nasal Cavity Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived10 of 10
→ investigated in trials for	Cisplatinsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants	—	—	Nasal Cavity Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Atezolizumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants

Nasal Cavity Carcinoma studied in …STUDIED_INderived7 of 7
→ studied in	NCT06980038Phase 2 · recruiting Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 7 trials mapped (6 active)	—	—	Nasal Cavity Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05172245Phase 1 · recruiting Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer · condition mapped CURATED_BROADER · 7 trials mapped (6 active)	—	—	Nasal Cavity Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05063552Phase 2/Phase 3 · active not recruiting Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers · condition mapped CURATED_BROADER · 7 trials mapped (6 active)	—	—	Nasal Cavity Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05075980Phase 2 · active not recruiting Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study · condition mapped ONTOLOGY_EXACT · 7 trials mapped (6 active)	—	—	Nasal Cavity Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 7 trials mapped (6 active)	—	—	Nasal Cavity Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04870762Phase 2 · recruiting Customized 3D Printed Oral Stents During Head and Neck Radiotherapy · condition mapped ONTOLOGY_EXACT · 7 trials mapped (6 active)	—	—	Nasal Cavity Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03274414Phase 2 · completed A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages · condition mapped ONTOLOGY_EXACT · 7 trials mapped (6 active)	—	—	Nasal Cavity Adenocarcinoma	1	Observed	clinicaltrials	graph →

Nasal Cavity Carcinoma studied in …STUDIED_INderived7 of 7

→ studied in

NCT06980038Phase 2 · recruiting

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 7 trials mapped (6 active)

—

Nasal Cavity Squamous Cell Carcinoma

Observed

clinicaltrials

graph →

→ studied in

NCT05172245Phase 1 · recruiting

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer · condition mapped CURATED_BROADER · 7 trials mapped (6 active)

—

Nasal Cavity Squamous Cell Carcinoma

Observed

clinicaltrials

graph →

→ studied in

NCT05063552Phase 2/Phase 3 · active not recruiting

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers · condition mapped CURATED_BROADER · 7 trials mapped (6 active)

—

Nasal Cavity Squamous Cell Carcinoma

Observed

clinicaltrials

graph →

→ studied in

NCT05075980Phase 2 · active not recruiting

Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study · condition mapped ONTOLOGY_EXACT · 7 trials mapped (6 active)

—

Nasal Cavity Carcinoma

Observed

clinicaltrials

graph →

→ studied in

NCT02834013Phase 2 · active not recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 7 trials mapped (6 active)

—

Nasal Cavity Carcinoma

Observed

clinicaltrials

graph →

→ studied in

NCT04870762Phase 2 · recruiting

Customized 3D Printed Oral Stents During Head and Neck Radiotherapy · condition mapped ONTOLOGY_EXACT · 7 trials mapped (6 active)

—

Nasal Cavity Carcinoma

Observed

clinicaltrials

graph →

→ studied in

NCT03274414Phase 2 · completed

A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages · condition mapped ONTOLOGY_EXACT · 7 trials mapped (6 active)

—

Nasal Cavity Adenocarcinoma

Observed

clinicaltrials

graph →

Radial view

Every edge, grouped by relationship

Strongest chains